eConsent In Healthcare Market Size

eConsent in Healthcare Market was valued at USD 458.2 million in 2023 and is anticipated to witness growth at a CAGR of 10.6% between 2024 and 2032. The eConsent in the healthcare market is experiencing growth driven by the expansion and globalization of clinical trials, increasing awareness among patients, and the rise of telehealth and remote care services.

The globalization of clinical trials involves conducting studies across multiple countries and regions, each with its own regulatory requirements and cultural nuances. eConsent platforms provide a standardized yet flexible approach to obtaining informed consent, ensuring compliance with diverse regulatory frameworks. Digital consent forms can be easily adapted and translated to meet the specific needs of different jurisdictions, streamlining multinational clinical trial operations.

Additionally, eConsent solutions integrated with telehealth platforms enhance patient engagement by providing clear and easily understandable information about medical procedures, treatments, and clinical trials. Patients can access consent documents, educational materials, and multimedia resources online, ensuring they are well-informed before making decisions. This transparency and accessibility increase patient confidence and participation in their healthcare.

eConsent in healthcare refers to the electronic process of obtaining and managing informed consent from patients or clinical trial participants through digital platforms.